Sale!

Minimal Residual Disease (MRD) Monitoring for Multiple Myeloma

Original price was: R8,350.Current price is: R5,350.

-36%

Living with multiple myeloma requires careful monitoring to ensure your treatment is working effectively. Our Minimal Residual Disease (MRD) Monitoring test provides the most sensitive detection available, capable of finding just one cancer cell among one million normal cells. For only ZAR 5,350 (regularly ZAR 8,350), this advanced test gives you and your oncologist crucial information about your treatment response and helps detect potential relapse early. With rapid 3-working-day results and nationwide coverage including Johannesburg, Cape Town, and Durban, you can trust Oracle Genomics for accurate, reliable monitoring that brings peace of mind during your recovery journey.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

MRD Monitoring for Multiple Myeloma | ZAR 5
Minimal Residual Disease (MRD) Monitoring for Multiple Myeloma
R8,350 Original price was: R8,350.R5,350Current price is: R5,350.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Multiple Myeloma Recovery Journey

When you’re navigating life after multiple myeloma treatment, uncertainty can be overwhelming. You’ve fought hard through chemotherapy and other treatments, and now you deserve the clearest picture of your health status. Our Minimal Residual Disease (MRD) Monitoring provides that clarity – detecting even the smallest amounts of remaining cancer cells that standard tests might miss.

This isn’t just another test; it’s your pathway to peace of mind and proactive health management. Knowing your MRD status empowers you and your healthcare team to make informed decisions about your ongoing care.

Understanding MRD Monitoring: Your Early Warning System

Minimal Residual Disease refers to the small number of cancer cells that can remain in your body after treatment, even when you appear to be in remission. These cells are too few to be detected by conventional methods but can eventually lead to relapse if left undetected.

Our advanced flow cytometry technology can detect as few as one cancer cell among one million normal cells – giving you the most sensitive monitoring available in South Africa. This precision allows for early intervention if needed, potentially preventing full relapse.

Who Should Consider MRD Monitoring?

This test is specifically designed for individuals who have undergone treatment for multiple myeloma and want to:

  • Monitor treatment effectiveness with precision
  • Detect potential relapse at the earliest possible stage
  • Make informed decisions about maintenance therapy
  • Reduce anxiety about their remission status
  • Participate actively in their long-term health management

If you’re experiencing lingering uncertainty about your recovery or want the most accurate assessment of your treatment success, MRD monitoring provides the answers you need.

Why MRD Monitoring Matters for Your Health Journey

Early Detection Saves Lives: Catching residual disease early allows for timely intervention before full relapse occurs, potentially saving you from more intensive treatment later.

Personalised Treatment Guidance: Your MRD status helps your oncologist tailor your maintenance therapy, ensuring you receive the right level of care without unnecessary treatment.

Peace of Mind: Knowing your precise disease status reduces the anxiety that often accompanies cancer recovery, allowing you to focus on living your life fully.

Proactive Health Management: Rather than waiting for symptoms to appear, MRD monitoring puts you in control of your health journey.

Understanding Your Results: Clear Guidance for Your Peace of Mind

We understand that waiting for test results can be stressful. That’s why we provide:

  • Clear, Understandable Reports: Your results will be presented in straightforward language with clear explanations
  • Expert Interpretation: Our oncology specialists ensure you understand what your results mean for your specific situation
  • Next Steps Guidance: We provide clear recommendations for discussing results with your healthcare team
  • Rapid Turnaround: Results within 3 working days means less waiting and worrying

Whether your results show complete response or detect minimal residual disease, you’ll have the information and support needed to move forward confidently.

Invest in Your Health with Transparent Pricing

Test Description Regular Price Special Price Savings
Minimal Residual Disease (MRD) Monitoring for Multiple Myeloma ZAR 8,350 ZAR 5,350 ZAR 3,000

Test Details:

  • Turnaround Time: Sample collected daily by 9 AM; Results in 3 working days
  • Sample Type: Bone marrow aspirate (3 mL minimum)
  • Method: Advanced Flow Cytometry
  • Specialty: Oncology

Consider this an investment in your long-term health – early detection can prevent much higher costs associated with relapse treatment.

Why Trust Oracle Genomics for Your MRD Monitoring?

Nationwide Coverage: Available throughout South Africa including Johannesburg, Cape Town, Durban, Pretoria and surrounding areas

Medical Expertise: Our tests are developed and interpreted by oncology specialists with deep understanding of multiple myeloma

Advanced Technology: State-of-the-art flow cytometry equipment ensures the highest accuracy and sensitivity

Patient-Centred Care: We understand the emotional journey of cancer recovery and provide compassionate, supportive service

Proven Reliability: Thousands of South Africans trust Oracle Genomics for their critical health monitoring needs

Take the Next Step Toward Confident Recovery

Don’t let uncertainty cloud your recovery journey. With MRD monitoring, you gain the clarity needed to move forward with confidence.

Limited Time Special: Book now to secure your ZAR 5,350 pricing (regularly ZAR 8,350)



Early detection saves lives. Take control of your multiple myeloma recovery today.